镍
化学选择性
组合化学
循环伏安法
化学
吡啶
电化学
背景(考古学)
芳基
催化作用
卤化物
反应机理
微分脉冲伏安法
还原消去
配体(生物化学)
烷基
有机化学
物理化学
电极
古生物学
生物化学
受体
生物
作者
Gabriele Laudadio,Philipp Neigenfind,Áron Péter,Camille Rubel,Megan A. Emmanuel,Martins S. Oderinde,Tamara Ewing,Maximilian D. Palkowitz,Jack L. Sloane,Kevin W. Gillman,Daniel Ridge,Michael D. Mandler,Philippe Bolduc,Michael C. Nicastri,Benxiang Zhang,Sebastian Clementson,Nadia Nasser Petersen,Pablo Martín‐Gago,Pavel K. Mykhailiuk,Keary M. Engle,Phil S. Baran
标识
DOI:10.1002/anie.202314617
摘要
Abstract There is a pressing need, particularly in the field of drug discovery, for general methods that will enable direct coupling of tertiary alkyl fragments to (hetero)aryl halides. Herein a uniquely powerful and simple set of conditions for achieving this transformation with unparalleled generality and chemoselectivity is disclosed. This new protocol is placed in context with other recently reported methods, applied to simplify the routes of known bioactive building blocks molecules, and scaled up in both batch and flow. The role of pyridine additive as well as the mechanism of this reaction are interrogated through Cyclic Voltammetry studies, titration experiments, control reactions with Ni(0) and Ni(II)‐complexes, and ligand optimization data. Those studies indicate that the formation of a BINAPNi(0) is minimized and the formation of an active pyridine‐stabilized Ni(I) species is sustained during the reaction. Our preliminary mechanistic studies ruled out the involvement of Ni(0) species in this electrochemical cross‐coupling, which is mediated by Ni(I) species via a Ni(I)‐Ni(II)‐Ni(III)‐Ni(I) catalytic cycle.
科研通智能强力驱动
Strongly Powered by AbleSci AI